Published in J Gen Virol on June 01, 2007
Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein. J Virol (2008) 1.12
Cleavage of group 1 coronavirus spike proteins: how furin cleavage is traded off against heparan sulfate binding upon cell culture adaptation. J Virol (2008) 1.03
Differential role for low pH and cathepsin-mediated cleavage of the viral spike protein during entry of serotype II feline coronaviruses. Vet Microbiol (2008) 0.99
Genome organization and reverse genetic analysis of a type I feline coronavirus. J Virol (2007) 0.96
Molecular characterization of a new species in the genus Alphacoronavirus associated with mink epizootic catarrhal gastroenteritis. J Gen Virol (2011) 0.88
Canine enteric coronaviruses: emerging viral pathogens with distinct recombinant spike proteins. Viruses (2014) 0.86
Feline lectin activity is critical for the cellular entry of feline infectious peritonitis virus. J Virol (2010) 0.86
Chimeric feline coronaviruses that encode type II spike protein on type I genetic background display accelerated viral growth and altered receptor usage. J Virol (2009) 0.84
Characterization of a recombinant canine coronavirus with a distinct receptor-binding (S1) domain. Virology (2012) 0.83
Feline and canine coronaviruses: common genetic and pathobiological features. Adv Virol (2011) 0.82
Genotypic characterization of canine coronaviruses associated with fatal canine neonatal enteritis in the United States. J Clin Microbiol (2014) 0.81
Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene (1991) 38.64
An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res (1987) 36.83
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science (1996) 28.95
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature (2003) 8.77
SLAM (CDw150) is a cellular receptor for measles virus. Nature (2000) 6.07
A conserved mechanism of retrovirus restriction in mammals. Proc Natl Acad Sci U S A (2000) 4.88
Human aminopeptidase N is a receptor for human coronavirus 229E. Nature (1992) 3.91
Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J Virol (2000) 3.46
The molecular biology of coronaviruses. Adv Virus Res (2006) 3.40
Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci U S A (2004) 3.03
Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J Virol (1998) 2.74
Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I. J Virol (1996) 1.85
Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors. J Virol (2006) 1.49
Persistence and transmission of natural type I feline coronavirus infection. J Gen Virol (2003) 1.36
Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerg Infect Dis (2005) 1.36
The prevalence of types I and II feline coronavirus infections in cats. J Vet Med Sci (1992) 1.28
Prevalence of feline coronavirus types I and II in cats with histopathologically verified feline infectious peritonitis. Vet Microbiol (2004) 1.28
Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus. J Virol (1992) 1.24
Intracellular targeting signals contribute to localization of coronavirus spike proteins near the virus assembly site. J Virol (2004) 1.23
Differences in virus receptor for type I and type II feline infectious peritonitis virus. Arch Virol (1998) 1.11
Use of a reverse-transcriptase polymerase chain reaction for monitoring the shedding of feline coronavirus by healthy cats. Vet Rec (2001) 1.09
Expression of feline infectious peritonitis coronavirus antigens on the surface of feline macrophage-like cells. J Gen Virol (1983) 1.01
Genomic RNA sequence of Feline coronavirus strain FIPV WSU-79/1146. J Gen Virol (2005) 1.01
The role of feline aminopeptidase N as a receptor for infectious bronchitis virus. Brief review. Arch Virol (2002) 0.85
Enhancement of feline infectious peritonitis virus type I infection in cell cultures using low-speed centrifugation. J Virol Methods (1995) 0.83
Identification and characterization of a Penaeus monodon lymphoid cell-expressed receptor for the yellow head virus. J Virol (2006) 0.82
Feline and canine coronaviruses are released from the basolateral side of polarized epithelial LLC-PK1 cells expressing the recombinant feline aminopeptidase-N cDNA. Arch Virol (2001) 0.79
A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science (2011) 7.86
Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol (2011) 2.85
A contemporary view of coronavirus transcription. J Virol (2006) 2.47
Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain. EMBO J (2002) 2.30
Functional and genetic analysis of coronavirus replicase-transcriptase proteins. PLoS Pathog (2005) 1.52
Selective replication of coronavirus genomes that express nucleocapsid protein. J Virol (2005) 1.44
Recombinant mouse hepatitis virus strain A59 from cloned, full-length cDNA replicates to high titers in vitro and is fully pathogenic in vivo. J Virol (2005) 1.36
Antigenic drift in H5N1 avian influenza virus in poultry is driven by mutations in major antigenic sites of the hemagglutinin molecule analogous to those for human influenza virus. J Virol (2011) 1.14
Human coronavirus 229E papain-like proteases have overlapping specificities but distinct functions in viral replication. J Virol (2007) 1.12
Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA. J Gen Virol (2004) 1.07
Organ-specific attenuation of murine hepatitis virus strain A59 by replacement of catalytic residues in the putative viral cyclic phosphodiesterase ns2. J Virol (2009) 1.06
Mutations in haemagglutinin that affect receptor binding and pH stability increase replication of a PR8 influenza virus with H5 HA in the upper respiratory tract of ferrets and may contribute to transmissibility. J Gen Virol (2013) 1.05
The production and development of H7 Influenza virus pseudotypes for the study of humoral responses against avian viruses. J Mol Genet Med (2013) 1.03
Multigene RNA vector based on coronavirus transcription. J Virol (2003) 1.03
Genomic RNA sequence of Feline coronavirus strain FIPV WSU-79/1146. J Gen Virol (2005) 1.01
The distribution of the endogenous retroviruses HERV-K113 and HERV-K115 in health and disease. Genomics (2005) 1.00
Genomic RNA sequence of feline coronavirus strain FCoV C1Je. J Feline Med Surg (2007) 0.98
The ADP-ribose-1''-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses. J Gen Virol (2011) 0.93
Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination. PLoS One (2012) 0.91
A structural analysis of M protein in coronavirus assembly and morphology. J Struct Biol (2010) 0.90
Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection. J Infect Dis (2011) 0.89
The use of equine influenza pseudotypes for serological screening. J Mol Genet Med (2012) 0.88
Competitive fitness in coronaviruses is not correlated with size or number of double-membrane vesicles under reduced-temperature growth conditions. MBio (2014) 0.84
A new cistron in the murine hepatitis virus replicase gene. J Virol (2010) 0.84
Evaluation of real-time RT-PCR for the quantification of FCoV shedding in the faeces of domestic cats. J Feline Med Surg (2008) 0.82
Nucleocapsid protein expression facilitates coronavirus replication. Adv Exp Med Biol (2006) 0.81
Establishment of the eukaryotic cell lines for inducible control of SARS-CoV nucleocapsid gene expression. Virol Sin (2010) 0.80
Long distance reverse-transcription PCR. Methods Mol Biol (2002) 0.79
Identification and evaluation of coronavirus replicase inhibitors using a replicon cell line. Adv Exp Med Biol (2006) 0.78
Infection with 2009 H1N1 influenza virus primes for immunological memory in human nose-associated lymphoid tissue, offering cross-reactive immunity to H1N1 and avian H5N1 viruses. J Virol (2013) 0.78